title: Does pioglitazone, like troglitazone, increase serum levels of lipoprotein(a) in diabetic patients?
authors.forename: Y
authors.initials: Y
authors.lastname: Nagai
authors.forename: T
authors.initials: T
authors.lastname: Abe
authors.forename: G
authors.initials: G
authors.lastname: Nomura
mesh_terms: D002839:Chromans / Q000009:adverse effects*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D017270:Lipoprotein(a) / Q000097:blood*; D008297:Male; D008875:Middle Aged; D000077205:Pioglitazone; D013844:Thiazoles / Q000009:adverse effects*; D045162:Thiazolidinediones; D000077288:Troglitazone
chemical_list: D002839:Chromans; D007004:Hypoglycemic Agents; D017270:Lipoprotein(a); D013844:Thiazoles; D045162:Thiazolidinediones; D000077288:Troglitazone; D000077205:Pioglitazone